149 related articles for article (PubMed ID: 11323498)
1. Insulinoma-induced hypoglycemic death in mice is prevented with beta cell-specific gene therapy.
Tirone TA; Fagan SP; Templeton NS; Wang X; Brunicardi FC
Ann Surg; 2001 May; 233(5):603-11. PubMed ID: 11323498
[TBL] [Abstract][Full Text] [Related]
2. Cell-specific cytotoxicity of human pancreatic adenocarcinoma cells using rat insulin promoter thymidine kinase-directed gene therapy.
Tirone TA; Wang XP; Templeton NS; Lee T; Nguyen L; Fisher W; Brunicardi FC
World J Surg; 2004 Aug; 28(8):826-33. PubMed ID: 15457366
[TBL] [Abstract][Full Text] [Related]
3. Specific gene expression and therapy for pancreatic cancer using the cytosine deaminase gene directed by the rat insulin promoter.
Wang XP; Yazawa K; Yang J; Kohn D; Fisher WE; Brunicardi FC
J Gastrointest Surg; 2004 Jan; 8(1):98-108; discussion 106-8. PubMed ID: 14746841
[TBL] [Abstract][Full Text] [Related]
4. Enhanced cytotoxicity of RIPTK gene therapy of pancreatic cancer via PDX-1 co-delivery.
Liu S; Wang XP; Brunicardi FC
J Surg Res; 2007 Jan; 137(1):1-9. PubMed ID: 17161985
[TBL] [Abstract][Full Text] [Related]
5. A novel synthetic human insulin super promoter for targeting PDX-1-expressing pancreatic cancer.
Liu SH; Yu J; Sanchez R; Liu X; Heidt D; Willey J; Nemunaitis J; Brunicardi FC
Cancer Lett; 2018 Apr; 418():75-83. PubMed ID: 29309817
[TBL] [Abstract][Full Text] [Related]
6. Specific targeting of pancreatic islet cells in vivo by insulin-promoter-driven adenoviral conjugated reporter genes.
Wang X; Olmsted-Davis E; Davis A; Liu S; Li Z; Yang J; Brunicardi FC
World J Surg; 2006 Aug; 30(8):1543-52. PubMed ID: 16855800
[TBL] [Abstract][Full Text] [Related]
7. Multiple treatment cycles of liposome-encapsulated adenoviral RIP-TK gene therapy effectively ablate human pancreatic cancer cells in SCID mice.
Liu SH; Smyth-Templeton N; Davis AR; Davis EA; Ballian N; Li M; Liu H; Fisher W; Brunicardi FC
Surgery; 2011 Apr; 149(4):484-95. PubMed ID: 21295812
[TBL] [Abstract][Full Text] [Related]
8. Liposomal insulin promoter-thymidine kinase gene therapy followed by ganciclovir effectively ablates human pancreatic cancer in mice.
Wu JX; Liu SH; Nemunaitis JJ; Brunicardi FC
Cancer Lett; 2015 Apr; 359(2):206-10. PubMed ID: 25596375
[TBL] [Abstract][Full Text] [Related]
9. PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platform.
Liu SH; Rao DD; Nemunaitis J; Senzer N; Zhou G; Dawson D; Gingras MC; Wang Z; Gibbs R; Norman M; Templeton NS; Demayo FJ; O'Malley B; Sanchez R; Fisher WE; Brunicardi FC
PLoS One; 2012; 7(8):e40452. PubMed ID: 22905092
[TBL] [Abstract][Full Text] [Related]
10. The activation of the rat insulin gene II by BETA2 and PDX-1 in rat insulinoma cells is repressed by Pax6.
Wolf G; Hessabi B; Karkour A; Henrion U; Dahlhaus M; Ostmann A; Giese B; Fraunholz M; Grabarczyk P; Jack R; Walther R
Mol Endocrinol; 2010 Dec; 24(12):2331-42. PubMed ID: 20943817
[TBL] [Abstract][Full Text] [Related]
11. Effective ablation of pancreatic cancer cells in SCID mice using systemic adenoviral RIP-TK/GCV gene therapy.
Liu SH; Davis A; Li Z; Ballian N; Davis E; Wang XP; Fisher W; Brunicardi FC
J Surg Res; 2007 Jul; 141(1):45-52. PubMed ID: 17512546
[TBL] [Abstract][Full Text] [Related]
12. A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
Biochem Biophys Res Commun; 1998 Dec; 253(1):65-9. PubMed ID: 9875221
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated suicide-gene therapy using the herpes simplex virus thymidine kinase gene in cell and animal models of human prostate cancer: changes in tumour cell proliferative activity.
Cheon J; Kim HK; Moon DG; Yoon DK; Cho JH; Koh SK
BJU Int; 2000 Apr; 85(6):759-66. PubMed ID: 10759680
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of non-allelic insulin genes in rodent islet tumour cells.
Lund K; Blume N; Michelsen BK; Bucchini D; Madsen OD
J Mol Endocrinol; 1993 Dec; 11(3):305-18. PubMed ID: 8148038
[TBL] [Abstract][Full Text] [Related]
15. Tumor-specific promoter-driven adenoviral therapy for insulinoma.
Tseng AW; Chen C; Breslin MB; Lan MS
Cell Oncol (Dordr); 2016 Jun; 39(3):279-86. PubMed ID: 26902080
[TBL] [Abstract][Full Text] [Related]
16. Development of a transgenic mouse model using rat insulin promoter to drive the expression of CRE recombinase in a tissue-specific manner.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
Int J Pancreatol; 1999 Jun; 25(3):157-63. PubMed ID: 10453417
[TBL] [Abstract][Full Text] [Related]
17. Selective suicide gene therapy of colon cancer exploiting the urokinase plasminogen activator receptor promoter.
Teimoori-Toolabi L; Azadmanesh K; Amanzadeh A; Zeinali S
BioDrugs; 2010 Apr; 24(2):131-46. PubMed ID: 20199127
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of HSV-tk suicide gene therapy driven by the Grp78 stress-inducible promoter in esophagogastric junction and gastric adenocarcinomas.
Azatian A; Yu H; Dai W; Schneiders FI; Botelho NK; Lord RV
J Gastrointest Surg; 2009 Jun; 13(6):1044-51. PubMed ID: 19277794
[TBL] [Abstract][Full Text] [Related]
19. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
20. Suicide gene therapy with HSV-TK in pancreatic cancer has no effect in vivo in a mouse model.
Fogar P; Greco E; Basso D; Habeler W; Navaglia F; Zambon CF; Tormen D; Gallo N; Cecchetto A; Plebani M; Pedrazzoli S
Eur J Surg Oncol; 2003 Nov; 29(9):721-30. PubMed ID: 14602490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
